Health TrialsbyHealthPanel

The King's Brief Lnterstitial Lung Disease Questionnaire

ConditionInterstitial Lung Disease Due to Systemic Disease
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPamukkale University

About this trial

The aim of this study is to examine the validity and reliability of the Turkish Validity and Reliability of The King's Brief Interstitial Lung Disease Questionnaire (K-BILD) in Individuals with Interstitial Lung Involvement Secondary to Rheumatological Diseases.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Being 18 years of age or older,

Agreeing to participate in the study.

Disqualifiers

Presence of a neurological disease

Presence of any orthopedic problem that affects functionality

History of any orthopedic surgery in the last year

Inability to speak or understand Turkish fluently

Trial population

All patient-reported outcome measurements will be administered once, and King's Brief Interstitial Lung Disease Questionnaire will be administered twice, one week apart.

Trial design

Design model

Cohort

Time perspective

Cross-sectional

Treatments tested in this trial

  • patient reported outcome measures

    Behavioral

    King's Brief lnterstitial Lung Disease Questionnaire, Arthritis Impact Measurement Scales (AIMS2)-Short Form, Modified Medical Research Council (mMRC) Dyspnea Scale, Visual Analog Scale were evaluated.

Treatment groups

45 Participants
are divided into 1 treatment group
Group A: Group I1 intervention

Trial outcomes

Primary outcomes

1

King's Brief lnterstitial Lung Disease Questionnaire

It consists of 15 items and has a seven-point Likert scale.

Time frame
10 minutes

Secondary outcomes

1

Arthritis Impact Measurement Scales (AIMS2)-Short Form

AIMS2-SF is a 26-item shortened form of AIMS2 and covers five components of quality of life.

Time frame
15 minutes
2

Modified Medical Research Council (mMRC) Dyspnea Scale

This scale provides information about perceived levels of shortness of breath, consisting of five stages.

Time frame
5 minutes
3

Visual Analog Scale

In our study, "respiratory distress" will be assessed using the Visual Analog Scale. 0 will be defined as "I never experience respiratory distress," and 10 as "I do not always experience respiratory distress."

Time frame
3 minutes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Pamukkale University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: